Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pentech Pharmaceuticals Inc.

Latest From Pentech Pharmaceuticals Inc.

Deals Shaping The Medical Industry, February 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Testing Vivus' Staying Power

Vivus' first-year sales of its impotence drug surpassed even its most optimistic projections. But that very success led to problems, most notably manufacturing capacity shortfalls, that threaten not just future US growth, but the drug's European launch, just when Vivus is bracing for Pfizer's market entry.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pentech Pharmaceuticals Inc.
  • Senior Management
  • Al Hummel, Pres. & CEO
  • Contact Info
  • Pentech Pharmaceuticals Inc.
    Phone: (847) 459-9122
    417 Harvester Ct.
    Wheeling, IL 60090
    USA
UsernamePublicRestriction

Register